| 英文名称 | 中文名称 | CAS | MF |
|
EtofenaMate iMpurity C
|
依托芬那酯杂质 C
|
|
|
|
EtofenaMate iMpurity E
|
依托芬那酯杂质 E
|
|
|
|
ETOFENAMATE IMPURITY G
|
依托芬那酯杂质 G
|
|
|
|
EtofenaMate iMpurity A
|
依托芬那酯杂质 A
|
|
|
|
ETOFENAMATE MYRISTATE
|
依托芬那酯杂质
|
81427-99-8
|
C32H44F3NO5
|
|
ETOFENAMATE EPE(CRM STANDARD)
|
|
|
|
|
ETOFENAMATE FOR SYSTEM SUITABILITY EPE(CRM STANDARD)
|
|
|
|
|
etofenprox-desethyl
|
醚菊酯-脱乙基, 10ΜG /ΜL于环己烷
|
80854-21-3
|
C23H24O3
|
|
ETOFENAMATE IMPURITY G2-HYDROXYETHYL 2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO]-BENZOATE EPE(CRM STANDARD)
|
|
|
|
|
Etofenprox
|
醚菊酯
|
80844-07-1
|
C25H28O3
|
|
ETOFENPROX 20%EC
|
|
|
|
|
ETOFENPROX 95%TC
|
|
|
|
|
Etofenamate
|
依托芬那酯
|
30544-47-9
|
C18H18F3NO4
|
|
ETOFENAMATE
|
依托芬那酯
|
|
|
|
etofibrate 2-hydroxymethyl-2-(4-chlorophenoxy)-2-methyl propionate
|
丙酸 2-(4-氯苯氧基)-2-甲基-,2-羟基乙酯
|
31637-96-4
|
C12H15ClO4
|
|
etofibrate 2-hydroxymethylnicotinate
|
etofibrate 2-hydroxymethylnicotinate
|
3612-80-4
|
C8H9NO3
|
|
ETOFIBRATE
|
依托贝特
|
31637-97-5
|
C18H18ClNO5
|
|
Eu-DOTA-4AmC(M-503)
|
|
|
|
|
Eu-DOTA-4AMC
|
Eu-DOTA-4AMC
|
481668-57-9
|
C24H37EuN8O12
|
|
ET-18-OEt
|
|
78858-43-2
|
C28H60NO6P
|
|
Etoformin Hydrochloride
|
|
53597-26-5
|
C8H20ClN5
|
|
Etoformin
|
依托福明
|
45086-03-1
|
|
|
ESX protein
|
|
|
|
|
Esx1 protein
|
胚胎外精子同源蛋白1蛋白
|
|
|
|
Etofuradine
|
|
17692-35-2
|
C18H21N3O
|
|
Eudragit RL
|
|
51822-44-7
|
C10H19NO4
|
|
EUDRAGITNE30D
|
|
|
|
|
etoglucid
|
依托格鲁
|
1954-28-5
|
C12H22O6
|
|
(ETOH)2-CH-CH2-PEG RESIN
|
|
|
|
|
ETOFYLLINE CLOFIBRATE
|
益多酯
|
54504-70-0
|
C19H21ClN4O5
|
|
(1E,3S,9Z,11aR,12S,14R,14aR)-3,6,7,8,11,11a,12,13,14,14a-Decahydro-12,14-dihydroxy-3-(2-phenylethyl)-5H-cyclopent[e]oxacyclotridecin-5-one
|
|
62411-15-8
|
C23H30O4
|
|
Etolorex
|
依托雷司
|
54063-36-4
|
C12H18ClNO
|
|
Etoloxamine
|
|
1157-87-5
|
C19H25NO
|
|
Etolotifen
|
依托替芬
|
82140-22-5
|
|
|
ET-18-OME
|
|
|
|
|
ETOMIDATE EPE(CRM STANDARD)
|
|
|
|
|
etomidoline
|
依托多林
|
21590-92-1
|
C23H29N3O2
|
|
Etomidate
|
依托咪酯
|
33125-97-2
|
C14H16N2O2
|
|
Etomidate Injection
|
|
|
|
|
ETOMIDATE IMPURITY BMETHYL-1-[(1RS)-1-PHENYLETHYL]-1H-IMIDAZOLE-5-CARBOXYLATE EPE(CRM STANDARD)
|
|
|
|
|
(E)-3-(4-TOLUIDINO)-1-[4-(1H-1,2,4-TRIAZOL-1-YL)PHENYL]-2-PROPEN-1-ONE
|
|
685107-73-7
|
C18H16N4O
|
|
ETOMOXIR
|
|
|
C17H23ClO4
|
|
Etomoxir-coa
|
|
124122-91-4
|
C36H53ClN7O19P3S
|
|
(+)-ETOMOXIR SODIUM
|
(+)-ETOMOXIR SODIUM
|
|
C15H18ClNaO4
|
|
Etomoxir
|
2 - (6 - (4 - 氯苯)己基)环氧乙烷羧酸乙酯
|
82258-36-4
|
C17H23ClO4
|
|
ETONGESTREL
|
|
|
|
|
ETONITAZENE HYDROCHLORIDE--DEA SCHEDULE I ITEM
|
1-(二乙氨乙基)-2-(对乙氧基苄基)-5-硝基苯并咪唑
|
2053-25-0
|
C22H29ClN4O3
|
|
etonitazene
|
依托尼秦
|
911-65-9
|
C22H28N4O3
|
|
Etonitazene methanesulfonate
|
|
58-75-3
|
C23H32N4O6S
|
|
(2E,7S,8Z,10E)-9-Bromo-12-hydroxy-7-(benzyloxy)-2-methyl-2,8,10-dodecatrienoic acid methyl ester
|
|
|
C21H27BrO4
|
|
(2E,7S,8Z,10E)-9-Bromo-12-hydroxy-7-(benzyloxy)-2,8,10-dodecatrienoic acid methyl ester
|
|
|
C20H25BrO4
|
|
EUFECTIN TRANSFECTION REAGENT
|
|
|
|
|
Etonogestrel β-D-Glucuronide
|
|
|
C28H36O8
|
|
Etonogestrel-d7 (Major)
|
Etonogestrel-d7 (Major)
|
|
C22H28O2
|
|
Etonogestrel Sulfate Sodium Salt
|
|
|
C22H27NaO5S
|
|
etonogestrel+ethinylestradiol
|
炔雌醇+依托孕烯,复方
|
|
|
|
Etonogestrel-13C2,d2
|
|
|
|
|
Etonogestrel
|
依托孕烯
|
54048-10-1
|
C22H28O2
|
|
Etonogestrel-d6
|
Etonogestrel-d6
|
|
C22H22D6O2
|
|
(2E,7S,8Z,10E,12E)-9-Bromo-14-hydroxy-7-(benzyloxy)-2-methyl-2,8,10,12-tetradecatetraenoic acid methyl ester
|
|
|
C23H29BrO4
|
|
Etoperidone-d8 Hydrochloride
|
Etoperidone-d8 Hydrochloride
|
1329796-60-2
|
C19H29Cl2N5O
|
|
ETOPERIDONE
|
依托哌酮
|
52942-31-1
|
C19H28ClN5O
|
|
Etoperidone Hydrochloride
|
|
|
|
|
Etophylline
|
|
|
|
|
EU FERRITE
|
|
|
EuFe3O6
|
|
(2E,7S,8Z,10E)-14-(tert-Butyldiphenylsilyloxy)-9-(trimethylsilyl)-7-(benzyloxy)-2-methyl-2,8,10-tetradecatrienoic acid methyl ester
|
|
|
C42H58O4Si2
|
|
(2E,7S,8Z,10E)-14-(tert-Butyldiphenylsilyloxy)-9-bromo-7-(benzyloxy)-2-methyl-2,8,10-tetradecatrien-1-al
|
|
|
C38H47BrO3Si
|
|
(2E,7S,8Z,10E)-14-(tert-Butyldiphenylsilyloxy)-9-bromo-7-(benzyloxy)-2-methyl-2,8,10-tetradecatrienoic acid methyl ester
|
|
|
C39H49BrO4Si
|
|
(2E,7S,8Z,10E)-14-(tert-Butyldiphenylsilyloxy)-9-(trimethylsilyl)-7-(benzyloxy)-2-methyl-2,8,10-tetradecatrien-1-al
|
|
|
C41H56O3Si2
|
|
Etoposide-d3
|
依托泊苷-D3
|
|
C29H32O13
|
|
Etoposide 3',4'-Quinone
|
依托泊苷 3',4'-苯醌
|
105016-65-7
|
C28H28O13
|
|
Etoposide USP 24
|
|
|
|
|
Etoposide Capsules
|
|
|
|
|
EtoposideCapsule
|
|
|
|
|
ETOPOSIDE, [14C]-
|
|
|
C29H32O13
|
|
Etoposide
|
依托泊苷
|
33419-42-0
|
C29H32O13
|
|
ETOPOSIDE [3H(G)]
|
|
|
C29O13T32
|
|
Etoposide phosphate
|
磷酸依托泊苷
|
117091-64-2
|
C29H33O16P
|
|
Etoposide Injection
|
|
|
|
|
ETOPOSIDE, [3H]- 300-900 MCI(11.1-33.3 GBQ)/MMOL, MORPURE HPLC PURIFIED, DELIVERED >= 97% PURE WITH HPLC RADIOCHROMATOGRAM
|
|
|
|
|
ETOPOSIDE(RG)
|
|
|
|
|
etoposide glucuronide
|
|
100007-55-4
|
C35H40O19
|
|
etoposide 4'-sulfate
|
|
|
|
|
ETOPOSIDE(VP16-213),PICROETOPOSIDE,SHEEPANTI-
|
|
|
|
|
ETOPOSIDE
|
|
|
|
|
EtoposideInj.
|
|
|
|
|
Etoprindole
|
|
54063-37-5
|
C15H21N3O
|
|
ETO-2 protein
|
|
|
|
|
Etoprine
|
|
18588-57-3
|
C12H12Cl2N4
|
|
Etoricoxib-d3
|
依托考昔-D3
|
850896-71-8
|
C18H15ClN2O2S
|
|
Etoricoxib
|
依托考昔
|
202409-33-4
|
C18H15ClN2O2S
|
|
Etoricoxib
|
|
|
|
|
Etosalamide
|
Etosalamide
|
15302-15-5
|
C11H15NO3
|
|
Etorocoxib 13C D4
|
|
|
|
|
Etorphine Hydrochloride
|
|
|
|
|
ETORPHINE
|
乙烯啡
|
14521-96-1
|
C25H33NO4
|
|
ETPI HCL
|
S-乙基-N-[4-(三氟甲基)苯基]异硫脲盐酸盐
|
163490-78-6
|
C10H12ClF3N2S
|
|
ETOSUXIMIDE
|
|
|
|
|
(E)-3-(2-(tosylamino)phenyl)acrylic acid
|
|
|
C16H15NO4S
|
|
(E)-3-(1-tosyl-1H-pyrrol-2-yl)acrylic acid
|
|
|
C14H13NO4S
|